TNFRSF1A and metabolic dysfunction-associated steatotic liver disease: In some clinical studies, the expression of several DRs, including Fas, TRAIL-R1, TRAIL-R2, and TNF receptor 1(TNFR1), was shown to be increased in the livers of NAFLD patients [16–18].